Goldentree Asset Management LP bought 150,652 shares of Keenova Therapeutics plc at $89.25 to $91.00 a share (average $90.65) in 2 transactions, worth $13.7M in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 9,026,195 (+1.4%).
Goldentree Asset Management LP bought 295,716 shares of Keenova Therapeutics plc at $89.25 a share, worth $26.4M in total between Nov 5, 2026 and Nov 6, 2026. Shares held after the trade: 8,875,543 (+1.7%).